ABOUT US

Dr. Shankaracharya is a PhD-trained Bioinformatics Scientist and AI/ML Architect specializing in building intelligent genomic systems for biotech innovation. With over 12 years of experience across academia and industry, he designs production-ready AI frameworks that transform large-scale genomic and multi-omics data into predictive, therapeutic, and commercially actionable insights.

He has led advanced bioinformatics and AI initiatives at SeQure Dx, Prevention Genetics, University of Massachusetts Medical School, and MD Anderson Cancer Center, contributing to discoveries published in Nature Genetics, Neuron, Nature Communications, and Nature Biotechnology.

Dr. Shankaracharya develops AI-powered platforms across:

Genomics Intelligence

• Rare variant prioritization using supervised and statistical learning
   
• Structural variant and repeat expansion modeling
   
• Large-cohort analytics (>70,000 genomes)
   
• Predictive pathogenicity and risk scoring systems
   

CRISPR & Gene Editing AI

• Variant-aware guide RNA optimization
   
• Off-target prediction using ML-based risk profiling
   
• Multi-assay integration (Digenome-seq, GUIDE-seq, ONE-seq)
   
• Structural rearrangement detection and translocation modeling
   

Transcriptomics & Single-Cell AI

• Feature engineering from bulk and single-cell RNA-seq
   
• Predictive biomarker modeling
   
• Cell-state classification and clustering
   
• Integrative genomics–transcriptomics modeling
   

Multi-Omics Machine Learning

• Cross-modal feature integration
   
• Predictive disease modeling
   
• Therapeutic target nomination pipelines
   
• Population-scale genomic risk analytics
   

Unlike purely academic bioinformatics efforts, Dr. Shankaracharya builds production-grade systems:

• Python-based ML frameworks (Scikit-Learn, statistical modeling)
   
• Cloud-native deployment (AWS, Google Cloud, Terra)
   
• Dockerized, reproducible pipelines
   
• Nextflow workflow orchestration
   
• HPC and large-scale automation
   
• CI/CD-integrated analytics environments
   

He combines algorithmic rigor, scalable software architecture, and deep genomic domain expertise to help startups:

• Move from raw sequencing data to predictive models
   
• Productionize AI pipelines for regulatory or clinical environments
   
• De-risk CRISPR and gene editing programs
   
• Build defensible, data-driven IP
   
• Scale multi-omics platforms from prototype to enterprise
   

• AI-first biotech startups
   
• CRISPR and gene editing companies
   
• Genomic diagnostics platforms
   
• Multi-omics precision medicine ventures
   
• Therapeutics companies building data moats
   

Dr. Shankaracharya bridges computational intelligence with biological insight — turning genomic complexity into engineered intelligence that accelerates discovery and drives measurable impact.